| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.877 | 0.002 | 0.973 | Androgen antagonist | 0.915 0.002 DBMET03015 0.973 0.001 DB09389 0.353 0.005 DBMET03016 | DB09389 | |
| 0.818 | 0.002 | 0.876 | Estrogen agonist | 0.845 0.002 DBMET03015 0.876 0.002 DB09389 0.651 0.003 DBMET03016 | DB09389 | |
| 0.782 | 0.001 | 0.806 | Progesterone agonist | 0.723 0.001 DBMET03015 0.806 0.001 DB09389 0.423 0.001 DBMET03016 | DB09389 | |
| 0.773 | 0.001 | 0.881 | Progesterone antagonist | 0.794 0.001 DBMET03015 0.881 0.001 DB09389 0.291 0.004 DBMET03016 | DB09389 | |
| 0.711 | 0.001 | 0.753 | Lipocortins synthesis antagonist | 0.753 0.001 DBMET03015 0.666 0.001 DB09389 0.526 0.003 DBMET03016 | DBMET03015 | |
| 0.676 | 0.035 | 0.781 | Antiinflammatory | 0.637 0.044 DBMET03015 0.709 0.029 DB09389 0.781 0.018 DBMET03016 | DBMET03016 | |
| 0.638 | 0.001 | 0.976 | Androgen agonist | 0.862 0.001 DBMET03015 0.976 0.001 DB09389 0.459 0.002 DBMET03016 | DB09389 | |
| 0.571 | 0.017 | 0.571 | Immunosuppressant | 0.526 0.026 DBMET03015 0.482 0.038 DB09389 0.534 0.024 DBMET03016 | ||
| 0.545 | 0.062 | 0.663 | Apoptosis agonist | 0.529 0.066 DBMET03015 0.532 0.065 DB09389 0.663 0.037 DBMET03016 | DBMET03016 | |
| 0.459 | 0.019 | 0.654 | Hypoxia-inducible factor 1 alpha inhibitor | 0.562 0.009 DBMET03015 0.654 0.005 DB09389 0.611 0.007 DBMET03016 | DB09389 | |
| 0.398 | 0.004 | 0.821 | Aromatase inhibitor | 0.476 0.003 DBMET03015 0.821 0.002 DB09389 0.22 0.008 DBMET03016 | DB09389 | |
| 0.386 | 0.022 | 0.494 | Sodium/bile acid cotransporter inhibitor | 0.451 0.007 DBMET03015 0.494 0.004 DB09389 0.414 0.013 DBMET03016 | DB09389 | |
| 0.415 | 0.06 | 0.857 | Transcription factor NF kappa B inhibitor | 0.453 0.052 DBMET03015 0.677 0.023 DB09389 0.857 0.009 DBMET03016 | DBMET03016 | |
| 0.323 | 0.005 | 0.716 | Estrogen antagonist | 0.517 0.004 DBMET03015 0.716 0.003 DB09389 0.336 0.005 DBMET03016 | DB09389 | |
| 0.286 | 0.003 | 0.687 | Glucocorticoid antagonist | 0.404 0.002 DBMET03015 0.687 0.001 DB09389 0.221 0.003 DBMET03016 | DB09389 | |
| 0.262 | 0.011 | 0.312 | Death-associated protein kinase 2 inhibitor | 0.312 0.006 DBMET03015 | DBMET03015 | |
| 0.245 | 0.002 | 0.931 | Anabolic | 0.255 0.002 DBMET03015 0.931 0 DB09389 0.301 0.001 DBMET03016 | DB09389 | |
| 0.272 | 0.041 | 0.717 | Anesthetic general | 0.347 0.024 DBMET03015 0.665 0.004 DB09389 0.717 0.003 DBMET03016 | DBMET03016 | |
| 0.297 | 0.067 | 0.948 | Aldehyde oxidase inhibitor | 0.689 0.009 DBMET03015 0.948 0.002 DB09389 0.444 0.041 DBMET03016 | DB09389 | |
| 0.225 | 0.004 | 0.586 | Mineralocorticoid receptor antagonist | 0.355 0.003 DBMET03015 0.586 0.002 DB09389 0.243 0.004 DBMET03016 | DB09389 | |
| 0.259 | 0.049 | 0.459 | Nitric oxide antagonist | 0.243 0.054 DBMET03015 0.328 0.035 DB09389 0.459 0.019 DBMET03016 | DBMET03016 | |
| 0.208 | 0.004 | 0.466 | Estrogen receptor beta agonist | 0.352 0.003 DBMET03015 0.466 0.003 DB09389 0.255 0.004 DBMET03016 | DB09389 | |
| 0.203 | 0.004 | 0.271 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.271 0.003 DBMET03015 0.226 0.003 DB09389 | DBMET03015 | |
| 0.204 | 0.009 | 0.549 | Estrogen receptor beta antagonist | 0.387 0.004 DBMET03015 0.549 0.003 DB09389 0.181 0.011 DBMET03016 | DB09389 | |
| 0.241 | 0.047 | 0.267 | Non-steroidal antiinflammatory agent | 0.147 0.118 DBMET03015 0.165 0.1 DB09389 0.267 0.037 DBMET03016 | DBMET03016 | |
| 0.199 | 0.005 | 0.522 | Estrogen receptor alpha agonist | 0.379 0.003 DBMET03015 0.522 0.002 DB09389 0.225 0.004 DBMET03016 | DB09389 | |
| 0.198 | 0.009 | 0.208 | Prolactin inhibitor | 0.124 0.036 DBMET03015 0.208 0.008 DB09389 | DB09389 | |
| 0.188 | 0.004 | 0.188 | Glycine receptor agonist | 0.163 0.005 DBMET03015 0.099 0.022 DB09389 0.113 0.015 DBMET03016 | ||
| 0.197 | 0.015 | 0.236 | Antineoplastic alkaloid | 0.201 0.013 DBMET03015 0.236 0.006 DB09389 0.138 0.031 DBMET03016 | DB09389 | |
| 0.207 | 0.027 | 0.28 | Arachidonic acid antagonist | 0.208 0.026 DBMET03015 0.28 0.003 DB09389 0.231 0.011 DBMET03016 | DB09389 | |
| 0.17 | 0.035 | 0.183 | Farnesoid X receptor antagonist | 0.183 0.028 DBMET03015 0.173 0.033 DB09389 0.126 0.091 DBMET03016 | DBMET03015 | |
| 0.151 | 0.038 | 0.177 | Death-associated protein kinase 1 inhibitor | 0.177 0.015 DBMET03015 | DBMET03015 | |
| 0.104 | 0.004 | 0.172 | Estrone sulfatase inhibitor | 0.152 0.003 DBMET03015 0.172 0.003 DB09389 0.067 0.005 DBMET03016 | DB09389 | |
| 0.163 | 0.066 | 0.744 | Diuretic | 0.229 0.035 DBMET03015 0.603 0.005 DB09389 0.744 0.003 DBMET03016 | DBMET03016 | |
| 0.1 | 0.005 | 0.116 | Lipocortins synthesis agonist | 0.094 0.007 DBMET03015 0.116 0.003 DB09389 0.103 0.005 DBMET03016 | DB09389 | |
| 0.113 | 0.021 | 0.136 | Na+ K+ transporting ATPase inhibitor | 0.118 0.017 DBMET03015 0.114 0.02 DB09389 0.136 0.009 DBMET03016 | DBMET03016 | |
| 0.111 | 0.022 | 0.774 | Estrogen receptor alpha antagonist | 0.295 0.005 DBMET03015 0.774 0.002 DB09389 0.113 0.021 DBMET03016 | DB09389 | |
| 0.149 | 0.06 | 0.24 | Bone formation stimulant | 0.179 0.042 DBMET03015 0.24 0.027 DB09389 0.164 0.05 DBMET03016 | DB09389 | |
| 0.098 | 0.01 | 0.228 | 5-Alpha-reductase inhibitor | 0.105 0.009 DBMET03015 0.228 0.004 DB09389 0.081 0.012 DBMET03016 | DB09389 | |
| 0.087 | 0.004 | 0.096 | Acid-sensing ion channel blocker | 0.096 0.004 DBMET03015 | DBMET03015 | |
| 0.108 | 0.026 | 0.177 | Glycine receptor antagonist | 0.149 0.008 DBMET03015 0.144 0.009 DB09389 0.177 0.004 DBMET03016 | DBMET03016 | |
| 0.218 | 0.145 | 0.218 | Caspase 3 stimulant | 0.201 0.167 DBMET03016 | ||
| 0.142 | 0.073 | 0.323 | Lipid peroxidase inhibitor | 0.195 0.044 DBMET03015 0.313 0.017 DB09389 0.323 0.016 DBMET03016 | DBMET03016 | |
| 0.104 | 0.04 | 0.115 | Ornithine decarboxylase inhibitor | 0.115 0.03 DB09389 0.093 0.052 DBMET03016 | DB09389 | |
| 0.076 | 0.014 | 0.377 | Estradiol 17 beta-dehydrogenase inhibitor | 0.203 0.004 DBMET03015 0.377 0.003 DB09389 | DB09389 | |
| 0.171 | 0.117 | 0.224 | Hypolipemic | 0.178 0.111 DBMET03015 0.224 0.08 DBMET03016 | DBMET03016 | |
| 0.063 | 0.011 | 0.205 | RNA-directed RNA polymerase stimulant | 0.088 0.007 DBMET03015 0.205 0.003 DB09389 0.115 0.005 DBMET03016 | DB09389 | |
| 0.06 | 0.02 | 0.502 | Aldosterone antagonist | 0.119 0.007 DBMET03015 0.502 0.002 DB09389 0.137 0.006 DBMET03016 | DB09389 | |
| 0.205 | 0.172 | 0.464 | Apoptosis antagonist | 0.315 0.076 DB09389 0.464 0.025 DBMET03016 | DBMET03016 | |
| 0.128 | 0.098 | 0.175 | Acetylcholine M1 receptor antagonist | 0.169 0.059 DBMET03015 0.175 0.055 DB09389 | DB09389 | |
| 0.084 | 0.057 | 0.084 | Acetylcholine M3 receptor agonist | |||
| 0.263 | 0.238 | 0.458 | Caspase 9 stimulant | 0.277 0.22 DBMET03015 0.397 0.113 DB09389 0.458 0.079 DBMET03016 | DBMET03016 | |
| 0.031 | 0.006 | 0.05 | Corticosteroid-like | 0.03 0.007 DBMET03015 0.05 0.003 DB09389 0.039 0.004 DBMET03016 | DB09389 | |
| 0.105 | 0.083 | 0.227 | Microtubule formation inhibitor | 0.098 0.095 DBMET03015 0.161 0.032 DB09389 0.227 0.014 DBMET03016 | DBMET03016 | |
| 0.055 | 0.035 | 0.077 | Acetylcholine M2 receptor agonist | 0.077 0.015 DBMET03015 0.063 0.025 DB09389 | DBMET03015 | |
| 0.023 | 0.007 | 0.072 | Glucocorticoid agonist | 0.045 0.005 DBMET03015 0.072 0.003 DB09389 0.027 0.006 DBMET03016 | DB09389 | |
| 0.072 | 0.06 | 0.159 | Keratolytic | 0.159 0.013 DB09389 0.069 0.067 DBMET03016 | DB09389 | |
| 0.085 | 0.075 | 0.085 | ABCA1 expression enhancer | |||
| 0.037 | 0.028 | 0.06 | Glucose-6-phosphate dehydrogenase inhibitor | 0.043 0.018 DBMET03015 0.06 0.007 DB09389 0.044 0.016 DBMET03016 | DB09389 | |
| 0.011 | 0.005 | 0.077 | Progesterone receptor A antagonist | 0.014 0.004 DBMET03015 0.077 0.002 DB09389 | DB09389 | |
| 0.031 | 0.03 | 0.031 | HMG CoA reductase inhibitor | |||
| 0.028 | 0.028 | 0.163 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.056 0.009 DBMET03015 0.163 0.003 DB09389 | DB09389 | |
| 0.017 | 0.018 | 0.087 | 5-Alpha-reductase 2 inhibitor | 0.087 0.005 DB09389 | DB09389 | |
| 0.148 | 0.155 | 0.196 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.196 0.076 DB09389 0.163 0.121 DBMET03016 | DB09389 | |
| 0.016 | 0.024 | 0.036 | Progesterone receptor B antagonist | 0.022 0.01 DBMET03015 0.036 0.004 DB09389 | DB09389 | |
| 0.028 | 0.037 | 0.05 | Estrogen-related receptor beta antagonist | 0.037 0.014 DBMET03015 0.05 0.005 DB09389 0.031 0.027 DBMET03016 | DB09389 | |
| 0.055 | 0.064 | 0.077 | Heme oxygenase stimulant | 0.061 0.043 DBMET03015 0.077 0.017 DB09389 0.062 0.042 DBMET03016 | DB09389 | |
| 0.009 | 0.021 | 0.018 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.018 0.003 DB09389 0.013 0.007 DBMET03016 | DB09389 | |
| 0.06 | 0.073 | 0.238 | Antineoplastic antibiotic | 0.103 0.045 DB09389 0.238 0.016 DBMET03016 | DBMET03016 | |
| 0.009 | 0.024 | 0.077 | 5-Alpha-reductase 1 inhibitor | 0.077 0.005 DB09389 | DB09389 | |
| 0.002 | 0.019 | 0.019 | Transcortin receptor antagonist | 0.019 0.001 DB09389 | DB09389 | |
| 0.012 | 0.032 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 DB09389 0.017 0.01 DBMET03016 | DBMET03016 | |
| 0.124 | 0.145 | 0.382 | Hepatoprotectant | 0.177 0.082 DB09389 0.382 0.015 DBMET03016 | DBMET03016 | |
| 0.038 | 0.062 | 0.058 | Alpha tubulin antagonist | 0.058 0.032 DB09389 | DB09389 | |
| 0.083 | 0.112 | 0.329 | Alkylator | 0.127 0.062 DB09389 0.329 0.011 DBMET03016 | DBMET03016 | |
| 0.087 | 0.117 | 0.121 | Tubulin antagonist | 0.121 0.079 DB09389 | DB09389 | |
| 0.035 | 0.065 | 0.122 | Protein 50S ribosomal subunit inhibitor | 0.122 0.009 DBMET03016 | DBMET03016 | |
| 0.086 | 0.118 | 0.132 | Cholinergic antagonist | 0.132 0.063 DB09389 | DB09389 | |
| 0.003 | 0.04 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 DBMET03016 | DBMET03016 | |
| 0.039 | 0.076 | 0.065 | Purinergic P2X2 antagonist | 0.065 0.049 DBMET03015 | DBMET03015 | |
| 0.031 | 0.07 | 0.044 | Microtubule stabilization | 0.044 0.035 DBMET03016 | DBMET03016 | |
| 0.01 | 0.052 | 0.031 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.022 0.016 DBMET03015 0.031 0.011 DB09389 | DB09389 | |
| 0.025 | 0.068 | 0.043 | GABA uptake inhibitor | 0.043 0.022 DBMET03015 0.042 0.024 DB09389 | DBMET03015 | |
| 0.112 | 0.156 | 0.421 | Interferon gamma antagonist | 0.268 0.025 DB09389 0.421 0.01 DBMET03016 | DBMET03016 | |
| 0.133 | 0.188 | 0.476 | Antioxidant | 0.198 0.115 DB09389 0.476 0.023 DBMET03016 | DBMET03016 | |
| 0.076 | 0.135 | 0.129 | Acetylcholine antagonist | 0.129 0.063 DB09389 | DB09389 | |
| 0.022 | 0.099 | 0.071 | Beta tubulin antagonist | 0.071 0.034 DB09389 | DB09389 | |
| 0.065 | 0.143 | 0.084 | Estrogen-related receptor beta agonist | 0.084 0.056 DB09389 | DB09389 | |
| 0.109 | 0.188 | 0.147 | Anticonvulsant | 0.147 0.133 DBMET03015 | DBMET03015 | |
| 0.032 | 0.113 | 0.044 | Parathyroid hormone antagonist | 0.044 0.035 DB09389 | DB09389 | |
| 0.044 | 0.13 | 0.106 | Acetylcholine nicotinic antagonist | 0.106 0.036 DB09389 | DB09389 | |
| 0.051 | 0.14 | 0.141 | Topoisomerase I inhibitor | 0.141 0.045 DBMET03016 | DBMET03016 | |
| 0.006 | 0.097 | 0.02 | Thyroid hormone alpha antagonist | 0.02 0.007 DB09389 | DB09389 | |
| 0.062 | 0.159 | 0.103 | Acetylcholine muscarinic antagonist | 0.103 0.087 DB09389 | DB09389 | |
| 0.011 | 0.115 | 0.038 | Protein 30S ribosomal subunit inhibitor | 0.038 0.01 DBMET03016 | DBMET03016 | |
| 0.099 | 0.207 | 0.189 | P-glycoprotein inhibitor | 0.189 0.072 DB09389 0.167 0.093 DBMET03016 | DB09389 | |
| 0.041 | 0.154 | 0.377 | Monophenol monooxygenase inhibitor | 0.221 0.028 DB09389 0.377 0.012 DBMET03016 | DBMET03016 | |
| 0.046 | 0.163 | 0.11 | Inducible nitric-oxide synthase inhibitor | 0.11 0.03 DB09389 | DB09389 | |
| 0.13 | 0.25 | 0.402 | DNA synthesis inhibitor | 0.247 0.068 DB09389 0.402 0.021 DBMET03016 | DBMET03016 | |
| 0.034 | 0.167 | 0.078 | Pregnane X receptor antagonist | 0.078 0.008 DB09389 | DB09389 | |
| 0.101 | 0.237 | 0.249 | Neurotrophic factor enhancer | 0.248 0.04 DB09389 0.249 0.039 DBMET03016 | DBMET03016 | |
| 0.049 | 0.193 | 0.143 | Cholesterol synthesis inhibitor | 0.143 0.048 DB09389 0.124 0.062 DBMET03016 | DB09389 | |
| 0.063 | 0.218 | 0.282 | Psychostimulant | 0.199 0.08 DB09389 0.282 0.048 DBMET03016 | DBMET03016 | |
| 0.016 | 0.176 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET03016 | DBMET03016 | |
| 0.019 | 0.18 | 0.074 | GABA receptor antagonist | 0.074 0.024 DB09389 | DB09389 | |
| 0.008 | 0.169 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 DBMET03016 | DBMET03016 | |
| 0.02 | 0.185 | 0.074 | GABA A receptor antagonist | 0.074 0.024 DB09389 | DB09389 | |
| 0.005 | 0.172 | 0.02 | Telomerase stimulant | 0.02 0.008 DBMET03016 | DBMET03016 | |
| 0.055 | 0.224 | 0.156 | Toll-Like receptor 4 antagonist | 0.093 0.082 DB09389 0.156 0.018 DBMET03016 | DBMET03016 | |
| 0.064 | 0.246 | 0.184 | Protein kinase stimulant | 0.184 0.048 DBMET03016 | DBMET03016 | |
| 0.021 | 0.206 | 0.112 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.112 0.008 DB09389 | DB09389 | |
| 0.044 | 0.23 | 0.129 | GABA receptor agonist | 0.129 0.049 DB09389 | DB09389 | |
| 0.139 | 0.329 | 0.423 | Interleukin 2 agonist | 0.274 0.094 DB09389 0.423 0.021 DBMET03016 | DBMET03016 | |
| 0.045 | 0.248 | 0.168 | DNA polymerase I inhibitor | 0.132 0.06 DB09389 0.168 0.04 DBMET03016 | DBMET03016 | |
| 0.02 | 0.226 | 0.068 | Adrenaline uptake inhibitor | 0.068 0.037 DB09389 | DB09389 | |
| 0.103 | 0.324 | 0.709 | Cholesterol antagonist | 0.423 0.045 DB09389 0.709 0.007 DBMET03016 | DBMET03016 | |
| 0.078 | 0.299 | 0.159 | Pregnane X receptor agonist | 0.159 0.039 DB09389 | DB09389 | |
| 0.011 | 0.235 | 0.068 | 5 Hydroxytryptamine uptake inhibitor | 0.068 0.04 DB09389 | DB09389 | |
| 0.046 | 0.272 | 0.12 | Transcription factor NF kappa B stimulant | 0.12 0.025 DBMET03016 | DBMET03016 | |
| 0.066 | 0.306 | 0.227 | Platelet antagonist | 0.227 0.084 DBMET03016 | DBMET03016 | |
| 0.07 | 0.31 | 0.269 | Melanin inhibitor | 0.167 0.062 DB09389 0.269 0.026 DBMET03016 | DBMET03016 | |
| 0.039 | 0.279 | 0.1 | Bile acid receptor antagonist | 0.1 0.05 DB09389 | DB09389 | |
| 0.065 | 0.311 | 0.334 | NOS3 expression enhancer | 0.227 0.032 DB09389 0.334 0.013 DBMET03016 | DBMET03016 | |
| 0.094 | 0.345 | 0.149 | CC chemokine 6 receptor antagonist | 0.122 0.105 DB09389 0.149 0.023 DBMET03016 | DBMET03016 | |
| 0.044 | 0.323 | 0.546 | Angiogenesis stimulant | 0.546 0.009 DBMET03016 | DBMET03016 | |
| 0.097 | 0.404 | 0.58 | Antibacterial | 0.58 0.022 DBMET03016 | DBMET03016 | |
| 0.082 | 0.395 | 0.59 | Antithrombotic | 0.59 0.017 DBMET03016 | DBMET03016 | |
| 0.056 | 0.386 | 0.215 | Tumour necrosis factor alpha release inhibitor | 0.215 0.097 DBMET03016 | DBMET03016 | |
| 0.041 | 0.374 | 0.219 | Cyclooxygenase 3 inhibitor | 0.219 0.013 DBMET03016 | DBMET03016 | |
| 0.077 | 0.459 | 0.193 | RNA-directed DNA polymerase inhibitor | 0.191 0.113 DB09389 0.193 0.111 DBMET03016 | DBMET03016 | |
| 0.023 | 0.413 | 0.108 | UDP-glucose 4-epimerase inhibitor | 0.108 0.052 DBMET03016 | DBMET03016 | |
| 0.033 | 0.438 | 0.395 | Immunostimulant | 0.395 0.051 DBMET03016 | DBMET03016 | |
| 0.037 | 0.447 | 0.362 | Free radical scavenger | 0.362 0.036 DBMET03016 | DBMET03016 | |
| 0.042 | 0.469 | 0.17 | Interleukin 6 antagonist | 0.139 0.108 DB09389 0.17 0.064 DBMET03016 | DBMET03016 | |
| 0.045 | 0.477 | 0.227 | DNA damaging | 0.19 0.124 DB09389 0.227 0.095 DBMET03016 | DBMET03016 | |
| 0.003 | 0.452 | 0.044 | Sodium/glucose cotransporter 2 inhibitor | 0.044 0.008 DBMET03016 | DBMET03016 | |
| 0.011 | 0.477 | 0.109 | Expectorant | 0.109 0.059 DBMET03016 | DBMET03016 | |
| 0.037 | 0.512 | 0.215 | Antipruritic | 0.215 0.04 DB09389 | DB09389 | |
| 0.041 | 0.519 | 0.145 | ATPase inhibitor | 0.145 0.11 DBMET03016 | DBMET03016 | |
| 0.018 | 0.516 | 0.096 | AMP-activated protein kinase stimulant | 0.096 0.076 DBMET03016 | DBMET03016 | |
| 0.05 | 0.577 | 0.244 | Immunomodulator | 0.244 0.12 DBMET03016 | DBMET03016 | |
| 0.033 | 0.578 | 0.244 | Interleukin agonist | 0.244 0.084 DBMET03016 | DBMET03016 | |
| 0.02 | 0.57 | 0.209 | Spasmolytic | 0.209 0.112 DBMET03016 | DBMET03016 | |
| 0.015 | 0.568 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.075 DBMET03016 | DBMET03016 | |
| 0.02 | 0.574 | 0.142 | Interleukin 8 antagonist | 0.142 0.039 DB09389 | DB09389 | |
| 0.003 | 0.559 | 0.032 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 DBMET03016 | DBMET03016 | |
| 0.045 | 0.612 | 0.197 | Vasodilator, coronary | 0.197 0.185 DBMET03016 | DBMET03016 | |
| 0.02 | 0.619 | 0.183 | Vasodilator | 0.183 0.119 DBMET03016 | DBMET03016 | |
| 0.02 | 0.64 | 0.131 | Insulin secretagoues | 0.131 0.096 DBMET03016 | DBMET03016 | |
| 0.024 | 0.765 | 0.378 | Hypoglycemic | 0.378 0.032 DBMET03016 | DBMET03016 | |
| 0.008 | 0.753 | 0.056 | Antibiotic Aminoglycoside-like | 0.056 0.01 DBMET03016 | DBMET03016 | |
| 0.016 | 0.784 | 0.101 | Amylase inhibitor | 0.101 0.096 DBMET03016 | DBMET03016 | |
| 0.009 | 0.8 | 0.179 | Thrombolytic | 0.179 0.063 DBMET03016 | DBMET03016 | |
| 0.008 | 0.807 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.04 DBMET03016 | DBMET03016 | |
| 0.014 | 0.813 | 0.227 | Platelet adhesion inhibitor | 0.227 0.058 DBMET03016 | DBMET03016 | |
| 0.004 | 0.806 | 0.201 | Selectin antagonist | 0.201 0.011 DBMET03016 | DBMET03016 | |
| 0.016 | 0.819 | 0.574 | Cyclophilin D inhibitor | 0.574 0.032 DBMET03016 | DBMET03016 | |
| 0.007 | 0.871 | 0.099 | Cell adhesion inhibitor | 0.099 0.092 DBMET03016 | DBMET03016 | |
| 0.049 | 0.914 | 0.323 | Peptidyltransferase inhibitor | 0.323 0.018 DBMET03016 | DBMET03016 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |